A Study to Investigate the Effects of RIST4721 on the Inflammatory Response in Healthy Male Subjects Using a Blister Model
Clinical trial NCT04105959 · COMPLETED
Trial details
- NCT number
- NCT04105959
- Sponsor
- Aristea Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-25
- Primary completion
- 2019-11-19
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.